Non-motor Symptoms in Patients with Parkinson’s Disease: A Cross-sectional Survey

Tanveer, Khushbakht; Attique, Immad; Sadiq, Waleed; Ahmad, Arsalan

doi:10.7759/cureus.3412

Cited by 11 publications

(11 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The most common severity level of the disease was stage III Hoehn & Yahr. This result is similar with the previous studies, which shows that stage III of Hoehn & Yahr PD severity assessment is more generally found in PD patients [15][16][17][18]. Stroke is the most commonly found comorbidity among the subjects.…”

Section: Discussionsupporting

confidence: 92%

Impact of Pain on Stroke and Hypertension as Comorbidities In Parkinson’s Disease

Wijaya

Pinzon

Jody

2019

AJBSR

View full text Add to dashboard Cite

This work is licensed under Creative Commons Attribution 4.0 License AJBSR.MS.ID.000519.Purpose: Pain is one of the most common non-motor symptom of Parkinson's Disease (PD) and related to disability, while the presence of comorbidity can deteriorate patient's quality of life. The relationship between pain and comorbidity in PD has not been clearly explored. Understanding pain and patient comorbidity especially stroke and hypertension is crucial in the management of PD.Objectives: This study aimed to report the prevalence and type of pain in patient with PD, and to determine the relationship between each type of pain and comorbidities (stroke and hypertension).Methods: This was a cross sectional study design. Data obtained from questionnaire filled by patients and hospital data registry at Bethesda Hospital, Yogyakarta. Pain was assessed using King's Parkinson's Disease Pain Scale (KPPS) questionnaire. Data were analysed descriptively and chi-square test for the pain correlation.Results: Thirty-one PD patients were recruited for this study, and most subjects were >70 years old (45.1%). Pain was present in over 22 patients (70.96%) consisted of 13 male (59.1%) and 9 females (40.9%). 20 subjects (64.5%) were in stage III Hoehn and Yahr as the most common severity level of disease. Stroke (74.2%) was more common than hypertension (38.7%) in PD patient. Musculoskeletal pain (45.2%) was the most common type of pain in PD patients and significantly correlate with stroke (45.2%, p<0.05), and orofacial pain (0%) as the least common type of pain. Chronic pain was also correlated with hypertension (16.1%, p<0.05). Conclusion:Pain is a frequent complaint in PD. Furthermore, some types of pain were correlated with stroke as well as hypertension as comorbidities in PD.

show abstract

Section: Discussionsupporting

confidence: 92%

Impact of Pain on Stroke and Hypertension as Comorbidities In Parkinson’s Disease

Wijaya

Pinzon

Jody

2019

AJBSR

View full text Add to dashboard Cite

show abstract

“…However, there remains relatively few studies that compare non-motor symptom prevalence in ethnically diverse samples. The Non-Motor Symptom Questionnaire was designed and validated in 2006 and has been used in different populations to enable comparison (see Table 2) [72][73][74][75][76][77][78][79][80][81][82][83][84]. All patients, regardless of ethnicity, appear to suffer from a high burden of non-motor symptoms.…”

Section: Ethnic Variation In Non-motor Symptoms Of Pdmentioning

confidence: 99%

Ethnic Variation in the Manifestation of Parkinson’s Disease: A Narrative Review

Ben-Joseph

Marshall

Lees

et al. 2020

JPD

View full text Add to dashboard Cite

The global prevalence of Parkinson's disease is increasing, yet the characteristics, risk factors and genetics of PD in Black, Asian and Hispanic populations is little understood. In this paper we review the published literature on clinical variation in the symptoms and signs of Parkinson's disease in different ethnic groups and responses to treatment. We included any study that sampled patients with Parkinson's disease from distinct ethnic backgrounds. We conclude that whilst there is little published evidence for ethnic variation in the clinical features of Parkinson's disease, there are substantial limitations and gaps in the current literature, which mean that the evidence does necessarily not fit with clinical observation. Possible explanations for expected differences in manifestation include genetic determinants, the coexistence of cerebrovascular disease and/or Alzheimer's disease pathology, healthcare inequalities and socio-cultural factors.

show abstract

“…As we mentioned earlier, all of the symptoms and conditions in Parkinson's disease could be divided in motor and nonmotor group. When we talk about nonmotor symptoms and conditions of Parkinson's disease, we can further subdivide them into autonomic and psychopathological or behavioural comorbidities (Tanveer, Attique, Sadiq, & Ahmad, 2018; Tibar et al, 2018). Autonomic comorbid conditions usually include pain, urinary, cardiovascular, thermoregulatory, sexual, and gastrointestinal dysfunctions.…”

Section: Introductionmentioning

confidence: 99%

Clinical practice guidelines based on evidence for cognitive‐behavioural therapy in Parkinson's disease comorbidities: A literature review

Zečević

2020

Clin Psychology and Psychoth

View full text Add to dashboard Cite

The purpose of this review is to provide psychologists and other health care professional enough knowledge about available cognitive‐behavioural interventions for comorbidities in Parkinson's disease that include depression, anxiety, impulsive disorder, pain, and sleep disturbances. This review has clear clinical practical suggestions how to adapt psychological interventions and techniques to the motor and/or cognitive impairments of patients with Parkinson's disease, based on earlier available research results. Every available research that could be found with the help of search engines from Medline, Springer, PsychINFO, and Google Scholar, which used cognitive‐behavioural therapy to treat Parkinson's comorbidities, was cited and explained. Cognitive‐behavioural interventions and techniques are presented based on available research results for Parkinson's comorbidities. It is recommended to use treatment plans and interventions that are earlier suggested as efficient in patients with Parkinson's disease. Strongest available research based recommendations are available for depression and anxiety. There are only few available research studies that used cognitive and/or behavioural interventions for pain, impulsive disorder, or sleeping disturbances, except insomnia in Parkinson's disease. Cognitive‐behavioural therapy is safe to use and should be adapted to the specific needs of patients and with the scientific approved treatment interventions and techniques. Psychologists should be careful on how they adapt their treatment plan for patients.

show abstract

Non-motor Symptoms in Patients with Parkinson’s Disease: A Cross-sectional Survey

Cited by 11 publications

References 19 publications

Impact of Pain on Stroke and Hypertension as Comorbidities In Parkinson’s Disease

Impact of Pain on Stroke and Hypertension as Comorbidities In Parkinson’s Disease

Ethnic Variation in the Manifestation of Parkinson’s Disease: A Narrative Review

Clinical practice guidelines based on evidence for cognitive‐behavioural therapy in Parkinson's disease comorbidities: A literature review

Contact Info

Product

Resources

About